Interleukin-13 associates with life-threatening rhinovirus infections in infants and young children.
Mauricio T CaballeroDiego R HijanoPatricio L AcostaCecilia G MateuDébora Natalia MarconeJodell E LinderLaura B TalaricoJohn M ElderMarcela EchavarriaEva Kathryn MillerFernando P Polacknull nullPublished in: Pediatric pulmonology (2018)
Targeted interventions against IL-13 should be evaluated to decrease severity of HRV illness in infancy and early childhood.